Blockchain Registration Transaction Record

Polyrizon (NASDAQ: PLRZ) Closes IPO, Raises $4.2M for Innovative Medical Device Hydrogels

Polyrizon (PLRZ) closes IPO, raising $4.2M in funding for medical device hydrogel technology. Aegis Capital Corp. has option to increase proceeds, emphasizing investor confidence in innovative healthcare solutions.

Polyrizon (NASDAQ: PLRZ) Closes IPO, Raises $4.2M for Innovative Medical Device Hydrogels

This news matters as Polyrizon's hydrogel technology could provide a breakthrough solution in protecting against viruses and allergens, potentially impacting public health and medical advancements. The successful IPO and additional funding showcase investor confidence in the company's innovative approach to medical device development.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x9f4d891bc4ed6eaf754c453089713b67c4fbb3b495d756fd8cb45e4dee01adcb
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintairycq3U-d32a9e0e1e522aec3459b4ce308a1f6c